BlueCrest Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-171,019
Closed -$1.56M 2011
2018
Q1
$1.56M Buy
+171,019
New +$1.56M 0.05% 342
2017
Q3
Sell
-14,280
Closed -$21K 1180
2017
Q2
$21K Buy
+14,280
New +$21K ﹤0.01% 856